SEC Form 4 · accession 0001209191-15-003197
SALIX PHARMACEUTICALS LTD · SLXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy J Creech
Officer — See Remarks
Period of report
Jan 2, 2015
Accepted (ET)
Jan 8, 2015 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001009356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2015 | F | 3,248 | $114.94 | D | 30,537 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
Remarks
Senior Vice President, Finance and Administrative Services, and Acting Chief Financial Officer